Nephro Care Share Price & Earnings Call Analysis

Financials of Nephro Care

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Nephro Care

Quarterly Results

Quarter-by-quarter operating performance

Dec 2025Mar 2026
Sales +22.6626.75
Expenses +20.7524.73
Operating Profit1.912.02
OPM %8.43%7.55%
Other Income +0.080.83
Interest0.03-0.01
Depreciation1.401.56
Profit before tax0.561.30
Tax %25.00%23.08%
Net Profit +0.421.00
EPS in Rs0.250.61

Financials of Nephro Care

Profit & Loss

Annual income statement trend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +0.541.823.4217.0927.2346.0388.73
Expenses +0.521.673.2813.6620.7640.1680.41
Operating Profit0.020.150.143.436.475.878.32
OPM %3.70%8.24%4.09%20.07%23.76%12.75%9.38%
Other Income +0.010.01-0.010.000.281.531.55
Interest0.040.030.020.070.090.110.16
Depreciation0.000.010.110.780.532.465.07
Profit before tax-0.010.120.002.586.134.834.64
Tax %0.00%25.00%7.75%28.06%24.64%27.37%
Net Profit +-0.010.09-0.012.374.413.643.37
EPS in Rs-10.0090.00-0.2047.403.712.212.04
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of Nephro Care

Balance Sheet

Capital structure and asset base

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.010.010.500.5011.9016.4916.49
Reserves0.070.010.002.033.1237.0040.37
Borrowings +0.400.692.542.480.000.000.00
Other Liabilities +0.300.421.603.255.9414.7915.81
Total Liabilities0.781.134.648.2620.9668.2872.67
Fixed Assets +0.450.061.393.014.7431.4834.12
CWIP0.000.451.900.000.860.610.43
Investments0.240.000.002.006.5118.5811.82
Other Assets +0.090.621.353.258.8517.6126.30
Total Assets0.781.134.648.2620.9668.2872.67

Financials of Nephro Care

Cash Flows

Operating, investing and financing cash movement

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +0.230.624.120.917.82
Cash from Investing Activity +-0.06-2.81-2.33-7.54-39.56
Cash from Financing Activity +0.282.32-0.085.6035.10
Net Cash Flow0.440.131.71-1.033.37
Free Cash Flow0.16-2.283.62-2.38-21.98
CFO/OP133%493%121%50%154%

Financials of Nephro Care

Ratios

Working capital efficiency and return ratios

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days0.000.0020.280.852.0125.6124.85
Inventory Days8.8341.9335.2514.0734.3831.68
Days Payable94.19113.4569.0375.17107.3292.84
Cash Conversion Cycle0.00-85.36-51.24-32.93-59.09-47.33-36.31
Working Capital Days-168.98-88.24-124.87-56.81-36.86-51.2337.10
ROCE %25.21%1.60%65.84%60.41%11.27%8.70%

Continue your research

Others in Healthcare Services this season

  • Manipal Health Enterprises Ltd (Q1 FY27)

    Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…

  • Fortis Healthcare Ltd (Q1 FY27)

    IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…

  • Metropolis Healthcare Ltd (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals Enterprise Ltd (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltdvs Max Healthcare Institute Ltdvs Manipal Health Enterprises Ltd